Skip to content

Disclosure Intervention for People in Treatment for Opioid Use Disorder

Disclosure Intervention to Reduce Social Isolation and Facilitate Recovery Among People in Treatment for Opioid Use Disorder

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06458985
Enrollment
480
Registered
2024-06-14
Start date
2024-05-20
Completion date
2028-08-31
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use Disorder

Keywords

disclosure, social isolation, stigma, social support

Brief summary

The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.

Interventions

The Disclosing Recovery intervention is designed to help people in treatment for opioid use disorder (1) make key decisions regarding disclosure, including whether, why, what, how, and when to disclose, and (2) build skills to disclose, including planning what to say, practicing disclosure, and preparing for negative responses.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Brandywine Counseling and Community Services
CollaboratorUNKNOWN
University of Delaware
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Client of Brandywine Counseling & Community Services * Receiving opioid use disorder treatment at Brandywine Counseling & Community Services * Considering disclosing one's opioid use disorder history and/or treatment to someone new

Exclusion criteria

* Diagnosis of schizophrenia * Participation in pilot study of intervention

Design outcomes

Primary

MeasureTime frameDescription
Retention in treatment1 yearWhether participants are retained in treatment 1 year after baseline
Illicit opioid use1 yearPercentages of drug screens that are positive for illicit opioid use

Secondary

MeasureTime frameDescription
Recovery capital score1 yearAverage scores on recovery capital measure (titled: Brief Assessment of Recovery Capital); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher values indicate greater recovery capital.
Quality of life score1 yearAverage scores on quality of life measure (titled: European Health Interview Survey-Quality of Life - 8 item); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher scores indicate greater quality of life.

Countries

United States

Contacts

Primary ContactValerie A Earnshaw, PhD
earnshaw@udel.edu1-302-831-4772

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026